Clinical Trial Update: Topotecan Pharmacokinetic Characterization Study [Phase 1]

View source ↗

Summary

Completed Phase 1 pharmacokinetic characterization study of topotecan sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 1 | Status: COMPLETED